CMBA
AMAG

C.M. Bidwell & Associates’s AMAG Pharmaceuticals AMAG Stock Holding History

C.M. Bidwell & Associates’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-14,944
Closed -$520K – 300
2016
Q4 		$520K Buy
+14,944
New +$446K 0.12% 99

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

C.M. Bidwell & Associates's AMAG Position: Q1 2017 in Review

C.M. Bidwell & Associates sold out of AMAG Pharmaceuticals (AMAG) in Q1 2017, closing a stake of 14,944 shares — an estimated $520K sold.

C.M. Bidwell & Associates first reported a position in AMAG in Q4 2016 and held it in 1 quarter. The position peaked at $520K in Q4 2016. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2017.

  • C.M. Bidwell & Associates reported no remaining AMAG Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 14,944 AMAG Pharmaceuticals shares in Q1 2017, an estimated $520K.
  • C.M. Bidwell & Associates first reported a position in AMAG Pharmaceuticals in Q4 2016 and held it in 1 quarter.
  • C.M. Bidwell & Associates's AMAG Pharmaceuticals position peaked at $520K in Q4 2016.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2017.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2017, filed 12 May 2017.